Lisa Dikomitis1, Trish Green2, Una Macleod3. 1. 1Lecturer in Social Research,School of Social Sciences,University of Hull,HU6 7RX,UK. 2. 2Research Fellow,Hull York Medical School,University of Hull,HU6 7RX,UK. 3. 3Professor of Primary Care Medicine,Hull York Medical School,University of Hull,HU6 7RX,UK.
Abstract
AIM: The purpose of this evaluation was to obtain views from general practitioners (GPs) who piloted the electronic risk assessment tools (eRATs) for suspected lung or colorectal cancer. We wanted to find out whether GPs were able to integrate these tools into their everyday practice. We were also keen to identify facilitators and barriers to their more widespread use. BACKGROUND: Cancer remains one of UK's biggest health problems, in terms of morbidity and mortality. Comparative European data show that five-year survival figures for many cancers are lower in the United Kingdom than in comparable European countries. eRATs are intended to aid recognition of symptoms of lung and colorectal cancers in patients aged 40 years and over. METHODS: This was a qualitative study; telephone interviews were conducted with 23 GPs who piloted the eRATs. A systematic qualitative analysis was applied to the data. The normalisation process model was used after data collection. This theory-driven conceptual framework was used to examine the operationalisation of this intervention in Primary Care. FINDINGS: Electronic decision-support tools appear to be useful additions to the resources available to GPs in order to assist them with recognizing potential cancer symptoms. However, the tools need to be refined in order to integrate them into GP practice. The tools raised GPs' awareness about cancer because of the prompt facility of the software, although this also raised the potential of 'prompt fatigue'. GPs constantly receive alerts via their clinical system, particularly related to the Quality and Outcomes Framework. The integration of eRATs into routine practice could be engendered by improvement to the training packages that accompany them, and by its delivery via a platform compatible with all GP clinical systems.
AIM: The purpose of this evaluation was to obtain views from general practitioners (GPs) who piloted the electronic risk assessment tools (eRATs) for suspected lung or colorectal cancer. We wanted to find out whether GPs were able to integrate these tools into their everyday practice. We were also keen to identify facilitators and barriers to their more widespread use. BACKGROUND:Cancer remains one of UK's biggest health problems, in terms of morbidity and mortality. Comparative European data show that five-year survival figures for many cancers are lower in the United Kingdom than in comparable European countries. eRATs are intended to aid recognition of symptoms of lung and colorectal cancers in patients aged 40 years and over. METHODS: This was a qualitative study; telephone interviews were conducted with 23 GPs who piloted the eRATs. A systematic qualitative analysis was applied to the data. The normalisation process model was used after data collection. This theory-driven conceptual framework was used to examine the operationalisation of this intervention in Primary Care. FINDINGS: Electronic decision-support tools appear to be useful additions to the resources available to GPs in order to assist them with recognizing potential cancer symptoms. However, the tools need to be refined in order to integrate them into GP practice. The tools raised GPs' awareness about cancer because of the prompt facility of the software, although this also raised the potential of 'prompt fatigue'. GPs constantly receive alerts via their clinical system, particularly related to the Quality and Outcomes Framework. The integration of eRATs into routine practice could be engendered by improvement to the training packages that accompany them, and by its delivery via a platform compatible with all GP clinical systems.
Entities:
Keywords:
cancer; decision support; early diagnosis; risk assessment
Authors: Sophie Chima; Jeanette C Reece; Kristi Milley; Shakira Milton; Jennifer G McIntosh; Jon D Emery Journal: Br J Gen Pract Date: 2019-11-28 Impact factor: 5.386
Authors: Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer Journal: Health Technol Assess Date: 2020-11 Impact factor: 4.014
Authors: Fiona M Walter; Jon D Emery; Silvia Mendonca; Nicola Hall; Helen C Morris; Katie Mills; Christina Dobson; Clare Bankhead; Margaret Johnson; Gary A Abel; Matthew D Rutter; William Hamilton; Greg P Rubin Journal: Br J Cancer Date: 2016-08-04 Impact factor: 7.640
Authors: Carl R May; Amanda Cummings; Melissa Girling; Mike Bracher; Frances S Mair; Christine M May; Elizabeth Murray; Michelle Myall; Tim Rapley; Tracy Finch Journal: Implement Sci Date: 2018-06-07 Impact factor: 7.327
Authors: M Nguyen; J Fujioka; K Wentlandt; N Onabajo; I Wong; R S Bhatia; O Bhattacharyya; V Stamenova Journal: BMC Palliat Care Date: 2020-09-07 Impact factor: 3.234